Pfizer announces shutting down of Parke – Davis Ann Arbor Facilities. Pfizer research fellows decide to try their hand at entrepreneurship and found AAPharmaSyn.

Bootstrapped, the company recruits former Ann Arbor Pfizer employees and opens its doors for business. Building on the legacy of excellence in synthetic chemistry, AAPharmaSyn finds customers and is profitable within the first year of operations.

AAPharmaSyn moves to a new facility with custom infrastructure to meet the needs of its customers. The company expands its services and hires additional employees. Successful track record of meeting deliverables on time and on schedule allows company to generate strong repeat business.

Founder transitions ownership to a new management team focused on continuing the legacy of investment in company capability and personnel.